Search

Your search keyword '"Mark Tiong"' showing total 4 results
Start Over Author "Mark Tiong"
4 results on '"Mark Tiong"'

1. Successful treatment of HIV‐associated lupus‐like glomerulonephritis with mycophenolic acid

Author

Mark Tiong, Scott Wilson, Alan Pham, and Anastasia Chrysostomou

Subjects
HIV Immune Complex Kidney disease, HIV‐associated kidney disease, Human immunodeficiency virus, Mycophenolic acid, Medicine, Medicine (General), R5-920
Abstract

Abstract HIV‐associated lupus‐like glomerulonephritis is an uncommon but well‐described entity. Treatment has traditionally focused on control of HIV viremia with some using adjuvant steroids. Mycophenolic acid may prove to be a novel, nonsteroid, therapy in patients with active glomerulonephritis despite control of the underlying infection.

Published
2020
Full Text
View/download PDF

2. Successful treatment of HIV‐associated lupus‐like glomerulonephritis with mycophenolic acid

Author

Anastasia Chrysostomou, Scott Wilson, Alan Pham, and Mark Tiong

Subjects
HIV Immune Complex Kidney disease, medicine.medical_treatment, Human immunodeficiency virus (HIV), lcsh:Medicine, Case Report, Viremia, Case Reports, 030204 cardiovascular system & hematology, medicine.disease_cause, Underlying infection, Mycophenolic acid, HIV‐associated kidney disease, 03 medical and health sciences, 0302 clinical medicine, medicine, In patient, lcsh:R5-920, Systemic lupus erythematosus, business.industry, Human immunodeficiency virus, lcsh:R, virus diseases, Glomerulonephritis, General Medicine, medicine.disease, 030220 oncology & carcinogenesis, Immunology, business, lcsh:Medicine (General), Adjuvant, medicine.drug
Abstract

HIV‐associated lupus‐like glomerulonephritis is an uncommon but well‐described entity. Treatment has traditionally focused on control of HIV viremia with some using adjuvant steroids. Mycophenolic acid may prove to be a novel, nonsteroid, therapy in patients with active glomerulonephritis despite control of the underlying infection.

Published
2020

4. Atraumatic splenic rupture following IVIg for parvovirus B19 pure red cell aplasia post renal transplant

Author

Joshua Casan, Catriona McLean, and Mark Tiong

Subjects
Male, medicine.medical_specialty, medicine.medical_treatment, Splenectomy, Pure red cell aplasia, Spleen, Red-Cell Aplasia, Pure, urologic and male genital diseases, Gastroenterology, Parvoviridae Infections, hemic and lymphatic diseases, Internal medicine, Parvovirus B19, Human, medicine, Humans, Transplantation, biology, Parvovirus, business.industry, Immunoglobulins, Intravenous, Anemia, Immunosuppression, Splenic Rupture, Middle Aged, biology.organism_classification, medicine.disease, Kidney Transplantation, Infectious Diseases, medicine.anatomical_structure, Renal transplant, Complication, business, Solid organ transplantation
Abstract

Parvovirus B19 (PB19) associated pure red cell aplasia (PRCA) is an uncommon but well described complication of immunosuppression post solid organ transplantation. We report a unique case of a renal transplant patient with PB19 associated PRCA who developed a spontaneous splenic rupture after receiving IVIg for persistent anemia. He subsequently required splenectomy. Within the spleen we subsequently identified PB19 affected cells.

Published
2019
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results